Kiniksa director exercises RSUs, gets new options

Kiniksa Pharmaceuticals International, plc director Cole G. Bradley reported equity compensation transactions.

Rhea-AI Filing Summary

Kiniksa Pharmaceuticals International, plc director Cole G. Bradley reported equity compensation transactions. Bradley exercised 2,799 Restricted Share Units that vested in a single installment into the same number of Class A Ordinary Shares, bringing his direct holdings to 15,345 shares. He also received 2,026 new Restricted Share Units that each represent one Class A Ordinary Share, vesting in full on the earlier of the grant anniversary or the next annual shareholder meeting. In addition, he was granted options on 12,158 Class A Ordinary Shares at an exercise price of $48.38 per share, vesting in twelve substantially equal monthly installments and expiring in 2036.

Insider Trade Summary

2,799 shares exercised/converted

Exercise 4 txns

Insider Cole G Bradley

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option	12,158	$0.00	$0.00
Grant/Award	Restricted Share Units	2,026	$0.00	$0.00
Exercise	Restricted Share Units	2,799	$0.00	$0.00
Exercise	Class A Ordinary Share	2,799	$0.00	$0.00

Holdings After Transaction: Share Option — 12,158 contracts (Direct); Restricted Share Units — 2,026 contracts (Direct); Class A Ordinary Share — 15,345 shares (Direct)

Footnotes (4)

1. F1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
2. F2. The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.
3. F3. The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.
4. F4. The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs.

Key Figures

RSUs exercised into shares: 2,799 shares Shares held after transactions: 15,345 shares New RSUs granted: 2,026 RSUs +4 more

7 metrics

RSUs exercised into shares 2,799 shares Class A Ordinary Shares acquired via RSU vesting on May 29, 2026

Shares held after transactions 15,345 shares Direct Class A Ordinary Share holdings following RSU exercise

New RSUs granted 2,026 RSUs Each RSU represents one Class A Ordinary Share, granted May 29, 2026

New options granted 12,158 options Share options on Class A Ordinary Shares granted May 29, 2026

Option exercise price $48.38 per share Conversion or exercise price for 12,158 share options

Option expiration date May 28, 2036 Expiration for the 12,158 granted share options

Derivative exercise shares 2,799 shares Total shares underlying derivative securities exercised in this filing

Key Terms

Restricted Share Unit (RSU), Class A Ordinary Share, Share Option, vests and becomes exercisable, +1 more

5 terms

Restricted Share Unit (RSU) financial

"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."

Class A Ordinary Share financial

"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."

A Class A ordinary share is a type of common stock a company issues that carries a specific set of rights—most often particular voting power, dividend terms, or transfer rules—distinct from other share classes. For investors it matters because those rights affect control over company decisions, how income is paid out, and how easy shares are to buy or sell; think of it like a tiered ticket that gives different access and influence at the same event.

Share Option financial

"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant"

vests and becomes exercisable financial

"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant"

annual meeting of shareholders financial

"the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Kiniksa (KNSA) director Cole G. Bradley report?

Cole G. Bradley reported equity compensation activity, including exercising 2,799 Restricted Share Units into Class A Ordinary Shares and receiving new grants of 2,026 RSUs and 12,158 share options as part of his director compensation package.

How many Kiniksa (KNSA) shares does Cole G. Bradley hold after this Form 4?

After exercising vested Restricted Share Units, Cole G. Bradley directly holds 15,345 Class A Ordinary Shares. These holdings reflect his position following the conversion of 2,799 RSUs into shares as reported in the Form 4 filing.

What new Restricted Share Units did Cole G. Bradley receive from Kiniksa (KNSA)?

Bradley received 2,026 new Restricted Share Units, each representing one Class A Ordinary Share. These RSUs vest in their entirety on the earlier of the grant’s one-year anniversary or the date of Kiniksa’s next annual meeting of shareholders, according to the footnotes.

What are the terms of the new Kiniksa (KNSA) share options granted to Cole G. Bradley?

Bradley was granted options on 12,158 Class A Ordinary Shares with an exercise price of $48.38 per share. The options vest in twelve substantially equal monthly installments and expire on May 28, 2036, providing long-term equity exposure.

How did the vested Kiniksa (KNSA) RSUs affect Cole G. Bradley’s derivative holdings?

The 2,799 Restricted Share Units vested in a single installment and were fully converted into Class A Ordinary Shares, leaving zero RSUs from that grant outstanding. This is reflected by the derivative position for those RSUs dropping to 0 in the Form 4 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cole G Bradley

(Last) (First) (Middle)

C/O KINIKSA PHARMACEUTICALS INT'L

105 PICCADILLY, SECOND FLOOR

(Street)

LONDON W1J 7NJ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [ KNSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Share	05/29/2026		M		2,799	A	(1)	15,345	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$48.38	05/29/2026		A		12,158		(2)	05/28/2036	Class A Ordinary Shares	12,158	$0	12,158	D
Restricted Share Units	(1)	05/29/2026		A		2,026		(3)	(3)	Class A Ordinary Shares	2,026	$0	2,026	D
Restricted Share Units	(1)	05/29/2026		M			2,799	(4)	(4)	Class A Ordinary Shares	2,799	$0	0	D

Explanation of Responses:

1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

2. The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.

3. The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.

4. The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs.

	/s/ Douglas Barry, Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)